Schmiegelow K - Search Results

1

Maintenance therapy of childhood acute lymphoblastic leukemia revisited-Should drug doses be adjusted by white blood cell, neutrophil, or lymphocyte counts?

Schmiegelow K, Nersting J, Nielsen SN, Heyman M, Wesenberg F, Kristinsson J, Vettenranta K, Schrøeder H, Weinshilboum R, Jensen KL, Grell K, Rosthoej S. Schmiegelow K, et al. Pediatr Blood Cancer. 2016 Dec;63(12):2104-2111. doi: 10.1002/pbc.26139. Epub 2016 Jul 22. Pediatr Blood Cancer. 2016. PMID: 27447547

2

Prognostic significance of methotrexate and 6-mercaptopurine dosage during maintenance chemotherapy for childhood acute lymphoblastic leukemia.

Schmiegelow K. Schmiegelow K. Pediatr Hematol Oncol. 1991 Oct-Dec;8(4):301-12. doi: 10.3109/08880019109028803. Pediatr Hematol Oncol. 1991. PMID: 1782110

3

Maintenance chemotherapy for childhood acute lymphoblastic leukemia: should dosage be guided by white blood cell counts?

Schmiegelow K, Pulczynska MK. Schmiegelow K, et al. Am J Pediatr Hematol Oncol. 1990 Winter;12(4):462-7. doi: 10.1097/00043426-199024000-00010. Am J Pediatr Hematol Oncol. 1990. PMID: 2285127

4

White-cell counts in childhood acute lymphoblastic leukemia.

Schmiegelow K, Pulczynska MK. Schmiegelow K, et al. Eur J Haematol. 1990 Jan;44(1):72-4. doi: 10.1111/j.1600-0609.1990.tb00351.x. Eur J Haematol. 1990. PMID: 2307222 No abstract available.

5

Prognostic significance of hepatotoxicity during maintenance chemotherapy for childhood acute lymphoblastic leukaemia.

Schmiegelow K, Pulczynska M. Schmiegelow K, et al. Br J Cancer. 1990 May;61(5):767-72. doi: 10.1038/bjc.1990.172. Br J Cancer. 1990. PMID: 2337515 Free PMC article.

6

6-Thioguanine nucleotide accumulation in red blood cells during maintenance chemotherapy for childhood acute lymphoblastic leukemia, and its relation to leukopenia.

Schmiegelow K, Bruunshuus I. Schmiegelow K, et al. Cancer Chemother Pharmacol. 1990;26(4):288-92. doi: 10.1007/BF02897232. Cancer Chemother Pharmacol. 1990. PMID: 2369793

7

Maintenance chemotherapy for childhood acute lymphoblastic leukemia: relation of bone-marrow and hepatotoxicity to the concentration of methotrexate in erythrocytes.

Schmiegelow K, Schrøder H, Pulczynska MK, Hejl M. Schmiegelow K, et al. Cancer Chemother Pharmacol. 1989;25(1):65-9. doi: 10.1007/BF00694341. Cancer Chemother Pharmacol. 1989. PMID: 2591003

8

White cell count during maintenance chemotherapy for standard-risk childhood acute lymphoblastic leukemia: relation to relapse rate.

Schmiegelow K, Pulczynska MK, Seip M. Schmiegelow K, et al. Pediatr Hematol Oncol. 1988;5(4):259-67. doi: 10.3109/08880018809037365. Pediatr Hematol Oncol. 1988. PMID: 3152971

9

Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology.

Schmiegelow K, Schrøder H, Gustafsson G, Kristinsson J, Glomstein A, Salmi T, Wranne L. Schmiegelow K, et al. J Clin Oncol. 1995 Feb;13(2):345-51. doi: 10.1200/JCO.1995.13.2.345. J Clin Oncol. 1995. PMID: 7531219

10

Transient pancytopenia preceding acute lymphoblastic leukemia (pre-ALL).

Hasle H, Heim S, Schroeder H, Schmiegelow K, Ostergaard E, Kerndrup G. Hasle H, et al. Among authors: schmiegelow k. Leukemia. 1995 Apr;9(4):605-8. Leukemia. 1995. PMID: 7723392

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

534 results

Search Page